STOCK TITAN

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced its participation in two major investor conferences in June 2022. The Jefferies Healthcare Conference features a fireside chat on June 9, 2022, at 4:30 p.m. ET, while the Goldman Sachs 43rd Annual Global Healthcare Conference will take place on June 15, 2022, at 9:20 a.m. PT. Both events will be available via live webcast and can be accessed from the company's website. Following the events, webcasts will be replayable for 90 days.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences in June:

  • Jefferies Healthcare Conference: Fireside chat on Thursday, June 9, 2022 at 4:30 p.m. ET.

  • Goldman Sachs 43rd Annual Global Healthcare Conference: Fireside chat on Wednesday, June 15, 2022 at 9:20 a.m. PT.

The conference events will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. Replays of the webcasts will be available for 90 days following the event.

About Apellis 
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in complement, we ushered in the first new class of complement medicine in 15 years with the approval of the first and only targeted C3 therapy. We are advancing this science to continually develop transformative medicines for people living with rare, retinal, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178


FAQ

What investor conferences is Apellis Pharmaceuticals attending in June 2022?

Apellis Pharmaceuticals is attending the Jefferies Healthcare Conference on June 9, 2022, and the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022.

When is the Jefferies Healthcare Conference for Apellis Pharmaceuticals?

The Jefferies Healthcare Conference will occur on June 9, 2022, at 4:30 p.m. ET.

What time is the Goldman Sachs Healthcare Conference for Apellis Pharmaceuticals?

The Goldman Sachs 43rd Annual Global Healthcare Conference is scheduled for June 15, 2022, at 9:20 a.m. PT.

How can I watch the Apellis Pharmaceuticals investor conference webcasts?

The webcasts can be accessed via the 'Events and Presentations' page on Apellis Pharmaceuticals' website.

Will the presentations from the investor conferences be available after the events?

Yes, replays of the webcasts will be available for 90 days following each event.

Apellis Pharmaceuticals, Inc.

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Stock Data

3.66B
105.50M
13.98%
97.43%
16.71%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WALTHAM